Old Problem, New Concerns: Hypercortisolemia in the Time of COVID-19

The ongoing coronavirus disease 2019 (COVID-19) pandemic forced a change in the way we provide medical treatment. Endocrinology in the era of COVID-19 had to transform and reduce its vast potential to the absolute necessities. Medical professionals needed to update their clinical practice to provide...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in endocrinology (Lausanne) Vol. 12; p. 711612
Main Authors Berlińska, Agata, Świątkowska-Stodulska, Renata, Sworczak, Krzysztof
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 05.10.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The ongoing coronavirus disease 2019 (COVID-19) pandemic forced a change in the way we provide medical treatment. Endocrinology in the era of COVID-19 had to transform and reduce its vast potential to the absolute necessities. Medical professionals needed to update their clinical practice to provide their patients as much support and as little harm as possible in these increasingly difficult times. International expert statements were published to offer guidance regarding proper care. It was suggested to simplify the diagnostic scheme of hypercortisolemia and to modify the approach to treatment. Hypercortisolemic patients with COVID-19 and iatrogenic hypercortisolemia due to glucocorticoid use are important clinical scenarios – we aimed to provide a cohesive summary of issues to consider.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
This article was submitted to Pituitary Endocrinology, a section of the journal Frontiers in Endocrinology
These authors have contributed equally to this work
Edited by: Jeff M. P. Holly, University of Bristol, United Kingdom
Reviewed by: Gherardo Mazziotti, University of Milan, Italy; Dimitra Argyro Vassiliadi, University General Hospital Attikon, Greece
ISSN:1664-2392
1664-2392
DOI:10.3389/fendo.2021.711612